CGTX today
$0.68+$0.01 (+1.06%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourBullish
1 hourStrong Bullish
15 minStrong Bullish
5 minSymmetric Triangle
Daily trend turns up above $0.74
Key levels
Resistance$0.88
Resistance$0.74
Support$0.63
Support$0.55
Latest news & SEC filings
LegalCognition Therapeutics gets Nasdaq bid price deficiency notice
EarningsCognition Therapeutics Posts Q3 2026 Results
SEC FilingCognition Therapeutics Inc filed a report on a major company event (Form 8-K)
EarningsCognition Therapeutics posts smaller quarterly loss than expected
All CGTX news →About Cognition Therapeutics
Cognition Therapeutics develops small molecule drugs aimed at degenerative conditions of the brain and eye that come with age. Its main experimental treatment, zervimesine (CT1812), is taken by mouth and works by keeping harmful protein clusters from attaching to nerve cell connections; it is being tested in Alzheimer's disease, dementia with Lewy bodies, and an eye condition called geographic atrophy. The company has no approved medicines and relies heavily on grants from the National Institute on Aging to pay for its studies.
Based on the company's 10-K filed Mar 26, 2026.
Nasdaq · Healthcare
COGNITION THERAPEUTICS INC (CGTX)
What Is the Price Target for CGTX?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is CGTX a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CGTX.
Start Free Trial →Is CGTX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B
Fair Value
$0.95
10
Moat Score
NONE
3/9
Piotroski Score
-6.0
Altman Z-Score
What Is Smart Money Doing with CGTX?
Insider Signal
NEUTRAL
3 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CGTX Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
62.79%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for CGTX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CGTX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:38:51 | $0.68 | 3,850 | $$3K | BUY |
| 20:07:46 | $0.68 | 2,800 | $$2K | BUY |
| 19:00:43 | $0.68 | 4,435 | $$3K | BUY |
| 18:56:38 | $0.68 | 2,000 | $$1K | SELL |
| 18:43:57 | $0.68 | 1,000 | $$676 | SELL |
5 dark pool trades shown · $$10K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for COGNITION THERAPEUTICS INC (CGTX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CGTX — frequently asked questions
What is CGTX stock price today?
COGNITION THERAPEUTICS INC (CGTX) is at $0.68, up 1.06% (+$0.01) at the Nov 11, 2026 close.
Why is CGTX stock moving today?
Latest CGTX news — Nov 5, 2026: Cognition Therapeutics gets Nasdaq bid price deficiency notice · Nov 5, 2026: Cognition Therapeutics Posts Q3 2026 Results
What do analysts rate CGTX?
Analyst ratings for CGTX: 3 Buy, 0 Hold, 0 Sell — consensus Strong Buy.
Did CGTX beat earnings?
CGTX last reported on Aug 6, 2026: EPS -$0.04 vs -$0.06 expected — a beat of 36.8%.
Does CGTX pay a dividend?
CGTX does not currently pay a dividend.
What are CGTX support and resistance levels?
Support: $0.63, $0.55, $0.47. Resistance: $0.74, $0.88, $0.99.
What are insiders doing with CGTX?
Insider activity: NEUTRAL, 3 buys and 0 sells in the last 90 days.
What is the latest news on CGTX?
Nov 5, 2026: Cognition Therapeutics gets Nasdaq bid price deficiency notice · Nov 5, 2026: Cognition Therapeutics Posts Q3 2026 Results · Nov 5, 2026: Cognition Therapeutics Inc filed a report on a major company event (Form 8-K)